JP2014517698A5 - - Google Patents

Download PDF

Info

Publication number
JP2014517698A5
JP2014517698A5 JP2014512858A JP2014512858A JP2014517698A5 JP 2014517698 A5 JP2014517698 A5 JP 2014517698A5 JP 2014512858 A JP2014512858 A JP 2014512858A JP 2014512858 A JP2014512858 A JP 2014512858A JP 2014517698 A5 JP2014517698 A5 JP 2014517698A5
Authority
JP
Japan
Prior art keywords
ngf
complex
pichia
subunit
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014512858A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014517698A (ja
JP6193220B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/036953 external-priority patent/WO2012161956A2/en
Publication of JP2014517698A publication Critical patent/JP2014517698A/ja
Publication of JP2014517698A5 publication Critical patent/JP2014517698A5/ja
Application granted granted Critical
Publication of JP6193220B2 publication Critical patent/JP6193220B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014512858A 2011-05-20 2012-05-08 形質転換されたピキア・パストリス(Pichiapastoris)などの微生物における抗体などのマルチサブユニットタンパク質の高純度生産 Active JP6193220B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201161488660P 2011-05-20 2011-05-20
US61/488,660 2011-05-20
US201161496873P 2011-06-14 2011-06-14
US201161496860P 2011-06-14 2011-06-14
US61/496,873 2011-06-14
US61/496,860 2011-06-14
US201161525307P 2011-08-19 2011-08-19
US61/525,307 2011-08-19
PCT/US2012/036953 WO2012161956A2 (en) 2011-05-20 2012-05-08 High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017119537A Division JP6491696B2 (ja) 2011-05-20 2017-06-19 形質転換されたピキア・パストリス(Pichia pastoris)などの微生物における抗体などのマルチサブユニットタンパク質の高純度生産

Publications (3)

Publication Number Publication Date
JP2014517698A JP2014517698A (ja) 2014-07-24
JP2014517698A5 true JP2014517698A5 (https=) 2015-06-25
JP6193220B2 JP6193220B2 (ja) 2017-09-06

Family

ID=47217961

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014512858A Active JP6193220B2 (ja) 2011-05-20 2012-05-08 形質転換されたピキア・パストリス(Pichiapastoris)などの微生物における抗体などのマルチサブユニットタンパク質の高純度生産
JP2017119537A Active JP6491696B2 (ja) 2011-05-20 2017-06-19 形質転換されたピキア・パストリス(Pichia pastoris)などの微生物における抗体などのマルチサブユニットタンパク質の高純度生産

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017119537A Active JP6491696B2 (ja) 2011-05-20 2017-06-19 形質転換されたピキア・パストリス(Pichia pastoris)などの微生物における抗体などのマルチサブユニットタンパク質の高純度生産

Country Status (21)

Country Link
EP (1) EP2710114B1 (https=)
JP (2) JP6193220B2 (https=)
KR (1) KR101981662B1 (https=)
CN (2) CN103827290A (https=)
CA (1) CA2837000C (https=)
CY (1) CY1124796T1 (https=)
DK (1) DK2710114T3 (https=)
EA (1) EA028913B9 (https=)
ES (1) ES2899381T3 (https=)
HR (1) HRP20211873T1 (https=)
HU (1) HUE060418T2 (https=)
IL (1) IL229430B (https=)
LT (1) LT2710114T (https=)
MX (2) MX368546B (https=)
PL (1) PL2710114T3 (https=)
PT (1) PT2710114T (https=)
RS (1) RS62628B1 (https=)
SG (1) SG194937A1 (https=)
SI (1) SI2710114T1 (https=)
SM (1) SMT202100677T1 (https=)
WO (1) WO2012161956A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20161439A1 (es) * 2014-03-21 2017-01-26 Teva Pharmaceuticals Int Gmbh Anticuerpos antagonistas dirigidos contra el peptido relacionado con el gen de calcitonina y metodos que usan los mismos
TWI734775B (zh) 2016-04-26 2021-08-01 美商美國泰福生技股份有限公司 細胞培養基
WO2018055574A1 (en) 2016-09-23 2018-03-29 Teva Pharmaceuticals International Gmbh Treating refractory migraine
GB201803832D0 (en) * 2018-03-09 2018-04-25 Syndermix Ag Methods and compositions for lectin production
CN108913732B (zh) * 2018-07-31 2022-02-08 华东理工大学 一种莫纳可林j异源生产的方法及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855231A (en) 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
US4818700A (en) 1985-10-25 1989-04-04 Phillips Petroleum Company Pichia pastoris argininosuccinate lyase gene and uses thereof
US4812405A (en) 1986-02-18 1989-03-14 Phillips Petroleum Company Double auxotrophic mutants of Pichia pastoris and methods for preparation
US4929555A (en) 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
WO1994021293A1 (en) 1993-03-19 1994-09-29 Duke University Method of treatment of tumors with an antibody binding to tenascin
ES2251723T3 (es) 1994-08-12 2006-05-01 Immunomedics, Inc. Inmunoconjugados y anticuerpos humanizados especificos para linfoma de celulas b y celulas de leucemia.
US5955349A (en) 1996-08-26 1999-09-21 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in Pichia methanolica
US5736383A (en) 1996-08-26 1998-04-07 Zymogenetics, Inc. Preparation of Pichia methanolica auxotrophic mutants
US6653104B2 (en) 1996-10-17 2003-11-25 Immunomedics, Inc. Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
US6730499B1 (en) 1998-07-03 2004-05-04 Research Corporation Technologies, Inc. Promoter for the Pichia pastoris formaldehyde dehydrogenase gene FLD1
US6258559B1 (en) 1999-03-22 2001-07-10 Zymogenetics, Inc. Method for producing proteins in transformed Pichia
AU3910000A (en) * 1999-03-22 2000-10-09 Zymogenetics Inc. Improved methods for producing proteins in transformed (pichia)
BR0116675A (pt) * 2000-12-13 2003-11-04 Unilever Nv Método de produção de uma proteìna heteróloga por um fungo e proteìna heteróloga
PT1678314E (pt) 2003-10-22 2012-11-27 Keck Graduate Inst Métodos de síntese de polipéptidos heteromultiméricos em levedura utilizando uma estratégia de conjugação haplóide
US8222386B2 (en) 2006-10-10 2012-07-17 Keck Graduate Institute P. pastoris ADH promoter and use thereof to direct expression of proteins
HUE032563T2 (en) 2007-05-21 2017-09-28 Alderbio Holdings Llc Antibodies to IL-6 and their use
KR20170036814A (ko) 2007-05-21 2017-04-03 앨더바이오 홀딩스 엘엘씨 신규한 래빗 항체 인간화 방법 및 인간화된 래빗 항체
JP6190723B2 (ja) * 2010-12-01 2017-08-30 アルダーバイオ ホールディングス エルエルシー 抗ngf組成物およびその使用

Similar Documents

Publication Publication Date Title
JP2014525395A5 (https=)
JP2014517698A5 (https=)
CY1121832T1 (el) Μονοκλωνικα αντισωματα κατα του παραγοντα αναπτυξεως και διαφοροποιησεως 15(gdf-15)
JP2012034696A5 (https=)
EA201491418A1 (ru) Рекомбинантные микроорганизмы и способы их применения
PH12013501683A1 (en) Yeast-based therapeutic for chronic hepatitis b infection
EP3564259A3 (en) Recognition tags for tgase-mediated conjugation
JP2013539454A5 (https=)
CY1121538T1 (el) Μονοκλωνικα αντισωματα εναντι του αναστολεα του μονοπατιου ιστικου παραγοντα (tfpi)
UA114902C2 (uk) Виділене антитіло, яке зв'язує парний спіральний філамент-тау (псф-тау), та фармацевтична композиція, що містить таке антитіло
CY1115030T1 (el) Διειδικα αντι-vegf/αντι-ang-2 αντισωματα
CY1119173T1 (el) Νεα μορια αναστολεα jnk
MX2014006158A (es) Metodos para el tratamiento de artritis psoriasica (psa) utilizando antagonistas de il-17 y alelos con respuesta o sin respuesta a la psa.
MX2013007904A (es) Anticuerpos anti-il-12/il-23 y usos de los mismos.
JP2013531106A5 (https=)
JP2018521691A5 (https=)
MX354717B (es) Moleculas de union novedosas con actividad antitumoral.
SG178886A1 (en) Humanized anti-cdcp1 antibodies
TR201909531T4 (tr) Anti-il-17 anti̇korlari kullanilarak anki̇lozan spondi̇li̇t tedavi̇ etme yöntemleri̇
EP4649999A3 (en) Methods for treating atopic dermatitis by administering an il-4r antagonist
EP4477668A3 (en) Heterodimeric antibody fc-containing proteins and methods for production thereof
UA96141C2 (ru) Нейтрализующее антитело, которое имеет специфичность к человеческому il-6
JP2014514960A5 (https=)
JP2015514423A5 (https=)
WO2012054929A3 (en) Use of human serum albumin to decrease antigenicity of therapeutic proteins